Clinical trials
Completed Phase 2 Immunoblastic Lymphadenopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 7 |
| National Cancer Institute (NCI) | 6 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Mayo Clinic | 3 |
| Case Comprehensive Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| BeiGene | 1 |
| City of Hope Medical Center | 1 |
| Deepa Jagadeesh | 1 |
| Hoag Memorial Hospital Presbyterian | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 36 |
| Lymphoma, Large-Cell, Anaplastic | 33 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 29 |
| Lymphoma, Large B-Cell, Diffuse | 28 |
| Lymphoma, Follicular | 26 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 26 |
| Burkitt Lymphoma | 25 |
| Lymphoma, Mantle-Cell | 25 |
| Lymphoma, Non-Hodgkin | 25 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 24 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.